Courtney Flynn
Biographic Data
| ID | 9996215 |
|---|---|
| NAME | Courtney Flynn |
| GIVEN NAMES | Courtney |
| FAMILY NAME | Flynn |
| SIGNATURE | FLYNN C |
| AFFILIATIONS | Indivior (United States) |
| VERIFIED | No |
| TOTAL WORKS | 1 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 1 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2026 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
Association between extended-release buprenorphine adherence and reduced healthcare costs among insured patients with opioid use disorder
Purpose: To evaluate the relationship between adherence to extended-release buprenorphine (BUP-XR; SUBLOCADE®) and reduced healthcare utilization and medical costs among patients with opioid use disorder (OUD). Methods: This retrospective analysis of United States insurance claims included patients aged ≥18 years who initiated BUP-XR between 3/1/2019-12/31/2022 (index = earliest BUP-XR claim) in the MerativeTM MarketScan® Commercial and Medicare …
No prominent works on this page.
Association between extended-release buprenorphine adherence and reduced healthcare costs among insured patients with opioid use disorder
Purpose: To evaluate the relationship between adherence to extended-release buprenorphine (BUP-XR; SUBLOCADE®) and reduced healthcare utilization and medical costs among patients with opioid use disorder (OUD). Methods: This retrospective analysis of United States insurance claims included patients aged ≥18 years who initiated BUP-XR between 3/1/2019-12/31/2022 (index = earliest BUP-XR claim) in the MerativeTM MarketScan® Commercial and Medicare …
Buprenorphine (1 work) · Group B (1 work) · Health care (1 work) · Health insurance (1 work) · HIV, Drug Use, Sexual Risk (1 work) · Medical costs (1 work) · Opioid use disorder (1 work) · Opioid Use Disorder Treatment (1 work) · Retrospective cohort study (1 work) · Substance Abuse Treatment and Outcomes (1 work)